Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kestra Medical TechnologiesKMTS -2.34%10 Current Ratio is 7.32 as of Jan. 2026, which is 160% above its 10-year median of 2.81. GuruFocus rates KMTS with a GF Score™ of 10/100. The stock has 4 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Kestra Medical Technologies ranks better than 87.6% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Kestra Medical Technologies's current ratio for the quarter that ended in Jan. 2026 was 7.32.
Kestra Medical Technologies has a current ratio of 7.32. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Kestra Medical Technologies's Current Ratio or its related term are showing as below:
KMTS'
s Current Ratio Range Over the Past 10 Years
Min: 0.45 Med: 2.81 Max: 7.32
Current: 7.32
During the past 4 years, Kestra Medical Technologies's highest Current Ratio was 7.32. The lowest was 0.45. And the median was 2.81.
KMTS's Current Ratio is ranked better than 87.6% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: 2.5
vs KMTS: 7.32
Kestra Medical Technologies (NAS:KMTS) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Kestra Medical Technologies Current Ratio Related Terms
Kestra Medical Technologies Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KMTS vs ATRC, STAA, BLFS: Current Ratio Comparison
For the Medical Instruments & Supplies subindustry, Kestra Medical Technologies's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kestra Medical Technologies Current Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Kestra Medical Technologies's Current Ratio distribution charts can be found below:
* The bar in red indicates where Kestra Medical Technologies's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kestra Medical Technologies (KMTS) has a Current Ratio of 7.32 as of Jan. 2026. This is 160% above median its historical median of 2.81. Over the past decade, Kestra Medical Technologies' Current Ratio has ranged from 0.45 to 7.32. According to the industry distribution chart, Kestra Medical Technologies ranks #106 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 12.4%.
Is Kestra Medical Technologies' Current Ratio too high?
Kestra Medical Technologies' current Current Ratio of 7.32 is 160% above median its 10-year median of 2.81. Over the past 10 years, this metric has ranged from a low of 0.45 to a high of 7.32. The Medical Devices & Instruments industry median Current Ratio is 2.50. Kestra Medical Technologies' value of 7.32 is 192.8% above this industry median. Based on the distribution chart, Kestra Medical Technologies ranks #106 out of 855 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Kestra Medical Technologies has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Kestra Medical Technologies' Current Ratio compare to ATRC and STAA?
According to the Medical Devices & Instruments industry distribution chart, Kestra Medical Technologies ranks #106 out of 855 companies for Current Ratio. This places Kestra Medical Technologies in the top 12% of its industry — outperforming the majority of peers. The industry median Current Ratio is 2.50. Kestra Medical Technologies' value of 7.32 is 192.8% above this benchmark. Historically, Kestra Medical Technologies' own Current Ratio has ranged from 0.45 to 7.32 over the past decade. While the company's 10-year median is 2.81 vs. the industry median of 2.50, Kestra Medical Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.50, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kestra Medical Technologies's current Current Ratio of 7.32 is 192.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kestra Medical Technologies's current Current Ratio is 7.32, which is 160% above median its own 10-year median of 2.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kestra Medical Technologies stock overvalued right now?
Kestra Medical Technologies (KMTS) has a current Current Ratio of 7.32. The current Current Ratio is 7.32, which is 160% above median its 10-year median of 2.81 and 192.8% above the Medical Devices & Instruments industry median of 2.50. Kestra Medical Technologies' overall GF Score™ is 10/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Kestra Medical Technologies (KMTS), the current Current Ratio is 7.32 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.
10GF Score
Get the complete analysis for KMTS
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KMTS has been successfully added to your 
